• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

88426-33-9 (Buparvaquone)

1

Identification

Buparvaquone Buparvaquone
Name Buparvaquone
Formula C21H26O3
MW 326.43
CAS No. 88426-33-9
EINECS
Smiles O=C1C(CC2CCC(C(C)(C)C)CC2)=C(O)C(C3=C1C=CC=C3)=O
Synonyms Butalex; 2-((4-(tert-butyl)cyclohexyl)methyl)-3-hydroxynaphthalene-1,4-dione
InChI InChI=1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3
2

Introduction

Buparvaquone(Butalex) is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone; it is a promising compound for the therapy and prophylaxis of all forms of theileriosis.

Background Information

Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. It is a promising compound for the therapy and prophylaxis of all forms of theileriosis. It has been shown to have antileishmanial activity in vitro. It can b ......by BOC Sciences
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. ......by MedChemexpress Co., Ltd.
A hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. ......by ProbeChem
1,​4-​Naphthalenedione, 2-​[[4-​(1,​1-​dimethylethyl)​cyclohexyl]​methyl]​-​3-​hydroxy- ......by Selleck Chemicals LLC
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:Light yellow to yellow Solid EBNumber:EB000010059

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways Anti-infection
Target Parasite
Research Area Infection
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Buparvaquone - Not Found
Buparvaquone - No Development Reported
7

Safety Data of Buparvaquone

8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 88426-33-9

Name CAS No Formula MW

Recommended Compounds in Parasite

Name CAS No Formula MW
milbemycin oxime 129496-10-2 C126H176N4O28 2194.76
Moxidectin 113507-06-5 C37H53NO8 639.82
Amprolium (hydrochloride) 137-88-2 C14H20Cl2N4 315.24
Bruceine A 25514-31-2 C26H34O11 522.54
GNF179 (Metabolite) 1310455-86-7 C14H16FN3 245.3
GNF179 1261114-01-5 C22H23ClFN5O 427.9
Artemotil 75887-54-6 C17H28O5 312.4012
Fumagillin 23110-15-8 C26H34O7 458.54
Ronidazole 7681-76-7 C6H8N4O4 200.15
Pentamidine (dihydrochloride) 50357-45-4 C19H26Cl2N4O2 413.34
Pentamidine 100-33-4 C19H24N4O2 340.42
Ornidazole 16773-42-5 C7H10ClN3O3 219.63
Clorsulon 60200-06-8 C8H8Cl3N3O4S2 380.66
Sulfadoxine 2447-57-6 C12H14N4O4S 310.33
Quinine (hydrochloride dihydrate) 6119-47-7 C20H29ClN2O4 396.91
Fenbendazole 43210-67-9 C15H13N3O2S 299.35
Haloxon 321-55-1 C14H14Cl3O6P 415.5901
Diclazuril 101831-37-2 C17H9Cl3N4O2 407.64
Metronidazole 443-48-1 C6H9N3O3 171.15
Oxibendazole 20559-55-1 C12H15N3O3 249.27

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

Buparvaquone

Tags: buy 88426-33-9 IC50 | 88426-33-9 price | 88426-33-9 cost | 88426-33-9 solubility | 88426-33-9 purchase | 88426-33-9 manufacturer | 88426-33-9 research buy | 88426-33-9 order | 88426-33-9 MSDS | 88426-33-9 chemical structure | 88426-33-9 Storage condition | 88426-33-9 molecular weight | 88426-33-9 mw | 88426-33-9 datasheet | 88426-33-9 supplier | 88426-33-9 cell line | 88426-33-9 NMR | 88426-33-9 MS | 88426-33-9 IR | 88426-33-9 solubility | 88426-33-9 Safe information | 88426-33-9 Qc and Spectral Information | 88426-33-9 Clinical Information | 88426-33-9 Clinical Trial | 88426-33-9 Route of Synthesis | 88426-33-9 storage condition | 88426-33-9 diseases and conditions | 88426-33-9 flash point | 88426-33-9 boiling point | 88426-33-9 melting point | 88426-33-9 storage condition | 88426-33-9 brand